4 mins read15 Oct 2025 11:03 PM IST
Business News›Vikas Dandekar
Stories by the author
Natco wins patent battle to launch generic 'Risdiplam'
3 mins read10 Oct 2025 12:00 AM IST
Sresan Pharma, maker of Coldrif, broke multiple rules: Officials
4 mins read08 Oct 2025 12:33 AM IST
'Indian generics safe, tariffs unwise': Indian pharma association hits back after US tariff concerns
5 mins read29 Sep 2025 01:42 AM IST
Weight-loss drug Ozempic to debut in India soon
3 mins read26 Sep 2025 11:36 PM IST
Delhi HC stops drug body from taking action against IndiaMart
4 mins read10 Sep 2025 11:23 PM IST
Natco Pharma sues Novo Nordisk in generic drug push
3 mins read21 Aug 2025 12:27 AM IST
Aurobindo Pharma closing in on $5.5b Zentiva buyout
7 mins read20 Aug 2025 05:01 AM IST
Indian drugmakers seek exemption for generics from US supplies probe
2 mins read19 Aug 2025 12:05 AM IST
Beijing doors ajar for trade package delivery
5 mins read14 Aug 2025 05:30 AM IST
Corner Office Conversation with The New Leaders of Indian Pharma
04 Aug 2025 07:00 AM IST
Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underway
5 mins read31 Jul 2025 05:30 AM IST
Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of ops
4 mins read28 Jul 2025 12:16 AM IST
Brookfield, EQT close in on Gland Pharma, but rising stock a pain
7 mins read21 Jul 2025 05:30 AM IST
From near bankruptcy to blockbuster drug: How Khorakiwala turned around Wockhardt
10 mins read21 Jul 2025
Zydus Life's plans for cancer biosimilar hit a legal hurdle
4 mins read21 Jul 2025 12:01 AM IST
Glenmark Pharmaceuticals targets 70% branded portfolio by 2030, boosts focus on novel drugs
3 mins read17 Jul 2025 12:45 AM IST
Glenmark, AbbVie ink $700 million drug licensing deal
5 mins read10 Jul 2025 08:38 PM IST
Aster DM Healthcare sets sights on smaller cities to expand play, grab top spot
5 mins read08 Jul 2025 12:28 AM IST
Delhi HC seeks regulator's reply after PIL questions Ozempic, Mounjaro nod
7 mins read02 Jul 2025 11:31 PM IST
Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financing
6 mins read27 Jun 2025 06:54 PM IST
Novo Nordisk aims for heavy sales in India with Wegovy
6 mins read24 Jun 2025 05:30 AM IST
Torrent Pharma keen to break into big league
4 mins read17 Jun 2025 11:59 PM IST
Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma
4 mins read14 Jun 2025 11:40 PM IST
One cough too many: India's TB fight isn't quite there yet
12 mins read08 Jun 2025 05:11 AM IST
Big fat legal war bursts out ahead of Novo Nordisk's Wegovy launch
3 mins read31 May 2025 05:30 AM IST
Leena Tiwari: Meet the billionaire owner of India's costliest flats
4 mins read29 May 2025 11:39 PM IST
Novartis offers payment plan for high-cost heart medicine
6 mins read27 May 2025 12:20 AM IST
Zydus working on single pen device for adjustable Semaglutide doses
3 mins read23 May 2025 12:16 AM IST
Non-AI organisations won't make it to 2050, says Diogo Rau
5 mins read17 May 2025 11:18 PM IST
Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw
5 mins read15 May 2025 12:17 AM IST
Trump’s drug price order raises alarm bells for Indian pharma
6 mins read13 May 2025 12:35 AM IST
Dr. Reddy's eyes aspirational goal to be in top five in the Indian market
4 mins read10 May 2025 05:34 PM IST
Revised rules for biosimilar drugs enter the final stretch
6 mins read06 May 2025 12:20 AM IST
Novo Nordisk to phase out key drug, insulin cos spot big biz opportunity
5 mins read23 Apr 2025 12:27 AM IST
Shedding weight may no longer be a prickly issue as Eli Lilly’s weight-loss pill moves closer to launch
4 mins read19 Apr 2025 05:30 AM IST
Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma giants
4 mins read15 Apr 2025 05:30 AM IST
Weight is over! Pharma companies race to make weight-loss drug semaglutide
4 mins read12 Apr 2025 06:00 AM IST
Tariff risks cloud near-term pharma deals outlook: Rothschild's Stefano Beschi
5 mins read10 Apr 2025 11:56 PM IST
Market volatility derails Novartis' plan to sell stake in its India arm
4 mins read01 Apr 2025 11:47 PM IST
Eli Lilly working on a heart drug that may benefit Indians: CEO David Ricks
4 mins read29 Mar 2025 01:01 AM IST
Morning Brief Podcast: Corner Office Conversation with Eli Lilly's Global CEO David Ricks
27 Mar 2025 08:00 AM IST
Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks
3 mins read26 Mar 2025 05:30 AM IST
Eli Lilly's goal is to reach everyone who needs obesity care: Global CEO David Ricks
6 mins read26 Mar 2025 12:08 AM IST
Big pharma mergers unlikely in near future: Dr Reddy's MD GV Prasad
5 mins read16 Mar 2025 11:07 PM IST
China’s biotech is redrawing the global pharma map; what India can learn
12 mins read15 Mar 2025 11:03 PM IST
ET Q&A: All our products are legitimate, sold under valid prescriptions, says Aveo Pharmaceuticals MD
3 mins read11 Mar 2025 12:03 AM IST
Reciprocal tariffs may make Indian generic drugs costlier in US: Pharma giants on Trump stance
4 mins read02 Mar 2025 05:23 AM IST